Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Justin Strickland, Johns Hopkins University School of Medicine. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Justin Strickland, Associate Professor of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine.
In the October 2025 podcast Justin Strickland talks about his work on e-cigarette withdrawal syndrome presented at the 13th Annual Vermont Center on Behavior and Health Conference, held in Vermont, USA. Justin is a behavioural pharmacologist working with substance use and substance use disorder. His research applies behavioural economic methods to evaluate choice and decision-making mechanisms that may underlie substance use and identify targets for their reduction. Justin begins by describing behavioral economics and how our environment and context shape the decisions we make, for example, how the cost of goods can influence patterns of consumption. As a relatively new class of products less is known about e-cigarette withdrawal than tobacco withdrawal syndrome. Justin describes his ongoing study of e-cigarette withdrawal syndrome among people who have exclusively used e-cigarettes. Participants stay in a residential unit for one week, where their behaviour, physiology and other measures, including their nicotine clearance, are measured. Preliminary findings indicate that participants do experience withdrawal to e-cigarettes, for example cravings that reduce over time. Looking to the future he calls for longer-term trials to observe behaviour and to explore predictors of complete cessation. Such research could inform the development of more effective behavioral interventions or pharmacological treatments to support individuals experiencing e-cigarette withdrawal.
This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches.
Our searches for the EC for smoking cessation review carried out on 1st October 2025 found: 1 new study (10.18332/852498tivblr); 2 ongoing new studies (ISRCTN12504090, 10.1177/29768357251337050); and 4 linked reports (10.1016/j.ypmed.2025.108414, 10.1037/pha0000803, 10.1093/ntr/ntaf200, 10.1101/2024.06.21.24309282).
Our search for our interventions for quitting vaping review carried out 1st October 2025 found: 1 new ongoing study (10.3389/fpubh.2025.1618341).
For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1
For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full
For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full
This podcast is supported by Cancer Research UK.
All content for Let's talk e-cigarettes is the property of Oxford University and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Justin Strickland, Johns Hopkins University School of Medicine. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Justin Strickland, Associate Professor of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine.
In the October 2025 podcast Justin Strickland talks about his work on e-cigarette withdrawal syndrome presented at the 13th Annual Vermont Center on Behavior and Health Conference, held in Vermont, USA. Justin is a behavioural pharmacologist working with substance use and substance use disorder. His research applies behavioural economic methods to evaluate choice and decision-making mechanisms that may underlie substance use and identify targets for their reduction. Justin begins by describing behavioral economics and how our environment and context shape the decisions we make, for example, how the cost of goods can influence patterns of consumption. As a relatively new class of products less is known about e-cigarette withdrawal than tobacco withdrawal syndrome. Justin describes his ongoing study of e-cigarette withdrawal syndrome among people who have exclusively used e-cigarettes. Participants stay in a residential unit for one week, where their behaviour, physiology and other measures, including their nicotine clearance, are measured. Preliminary findings indicate that participants do experience withdrawal to e-cigarettes, for example cravings that reduce over time. Looking to the future he calls for longer-term trials to observe behaviour and to explore predictors of complete cessation. Such research could inform the development of more effective behavioral interventions or pharmacological treatments to support individuals experiencing e-cigarette withdrawal.
This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches.
Our searches for the EC for smoking cessation review carried out on 1st October 2025 found: 1 new study (10.18332/852498tivblr); 2 ongoing new studies (ISRCTN12504090, 10.1177/29768357251337050); and 4 linked reports (10.1016/j.ypmed.2025.108414, 10.1037/pha0000803, 10.1093/ntr/ntaf200, 10.1101/2024.06.21.24309282).
Our search for our interventions for quitting vaping review carried out 1st October 2025 found: 1 new ongoing study (10.3389/fpubh.2025.1618341).
For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1
For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full
For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full
This podcast is supported by Cancer Research UK.
Let's talk e-cigarettes, September 2024, Ep 35 (Transcript)
Let's talk e-cigarettes
1 year ago
Let's talk e-cigarettes, September 2024, Ep 35 (Transcript)
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Benjamin Toll, Medical University of South Carolina Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Benjamin Toll, Medical University of South Carolina about his work and interventions to help people to quit vaping.
Professor Benjamin Toll is a clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. Ben Toll specialises in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviours.
In the September podcast Ben Tol describes how he became involved in this research field, about his smoking cessation work and about interventions to help people to quit vaping. Ben discusses some pilot studies of vaping cessation with Amanda Palmer and a study of varenicline for vaping cessation with Lisa Fucito. Ben talks about the importance of creating an evidence base to inform clinical practice guidelines for quitting vaping. At present there are very few studies looking at vaping cessation and Ben stresses the need for more studies in this field.
This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches.
Our literature searches carried out on 1st August & 1st September found: 1 new study (10.1093/ntr/ntae158), 5 new ongoing studies (DOI: 10.51847/c5AEETRrY9; DOI: 10.1186/s13722-024-00483-5; NCT06534905; NCT06543407; NCT06554873 ) & 3 linked papers.
For further details see our webpage under 'Monthly search findings':
https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1
For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full
This podcast is supported by Cancer Research UK.
Let's talk e-cigarettes
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Justin Strickland, Johns Hopkins University School of Medicine. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Justin Strickland, Associate Professor of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine.
In the October 2025 podcast Justin Strickland talks about his work on e-cigarette withdrawal syndrome presented at the 13th Annual Vermont Center on Behavior and Health Conference, held in Vermont, USA. Justin is a behavioural pharmacologist working with substance use and substance use disorder. His research applies behavioural economic methods to evaluate choice and decision-making mechanisms that may underlie substance use and identify targets for their reduction. Justin begins by describing behavioral economics and how our environment and context shape the decisions we make, for example, how the cost of goods can influence patterns of consumption. As a relatively new class of products less is known about e-cigarette withdrawal than tobacco withdrawal syndrome. Justin describes his ongoing study of e-cigarette withdrawal syndrome among people who have exclusively used e-cigarettes. Participants stay in a residential unit for one week, where their behaviour, physiology and other measures, including their nicotine clearance, are measured. Preliminary findings indicate that participants do experience withdrawal to e-cigarettes, for example cravings that reduce over time. Looking to the future he calls for longer-term trials to observe behaviour and to explore predictors of complete cessation. Such research could inform the development of more effective behavioral interventions or pharmacological treatments to support individuals experiencing e-cigarette withdrawal.
This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches.
Our searches for the EC for smoking cessation review carried out on 1st October 2025 found: 1 new study (10.18332/852498tivblr); 2 ongoing new studies (ISRCTN12504090, 10.1177/29768357251337050); and 4 linked reports (10.1016/j.ypmed.2025.108414, 10.1037/pha0000803, 10.1093/ntr/ntaf200, 10.1101/2024.06.21.24309282).
Our search for our interventions for quitting vaping review carried out 1st October 2025 found: 1 new ongoing study (10.3389/fpubh.2025.1618341).
For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1
For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full
For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full
This podcast is supported by Cancer Research UK.
